Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,620.13
1,499.80
1,378.11
1,349.26
1,107.74
1,118.72
981.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,620.13
1,499.80
1,378.11
1,349.26
1,107.74
1,118.72
981.88
Raw Material Cost
934.06
868.87
784.02
805.69
670.62
658.19
575.24
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
346.74
338.23
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
18.79
12.85
9.61
8.31
9.31
11.02
14.20
Selling and Distribution Expenses
275.62
260.99
263.61
260.25
235.31
187.01
214.96
Other Expenses
9.23
9.38
-26.60
-26.99
4.19
4.10
2.62
Total Expenditure (Excl Depreciation)
1,320.72
1,236.46
1,137.94
1,142.61
957.15
897.21
830.64
Operating Profit (PBDIT) excl Other Income
299.40000000000003
263.29999999999995
240.2
206.70000000000002
150.6
221.5
151.2
Other Income
11.13
22.51
21.41
27.72
5.62
-10.65
26.17
Operating Profit (PBDIT)
370.40
347.26
319.54
290.45
212.03
259.90
216.72
Interest
18.79
12.85
9.61
8.31
9.31
11.02
14.20
Exceptional Items
-145.13
2.32
0.08
-5.30
-3.83
-9.12
-9.75
Gross Profit (PBDT)
686.07
630.93
594.09
543.57
437.12
460.54
406.64
Depreciation
76.10
72.99
72.17
65.75
57.05
49.65
43.27
Profit Before Tax
130.38
263.74
237.84
211.09
141.84
190.12
149.50
Tax
43.16
34.57
32.70
27.90
25.55
30.23
23.24
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
76.33
219.39
192.49
166.57
106.09
153.11
121.14
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
76.33
219.39
192.49
166.57
106.09
153.11
121.14
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
10.80
9.08
12.12
11.18
8.58
6.77
3.35
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
87.13
228.47
204.60
177.75
114.67
159.88
124.49
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,761.69
1,884.98
1,817.10
1,723.87
1,578.48
1,134.17
1,027.61
Earnings per share (EPS)
0.26
0.75
0.66
0.58
0.41
0.59
0.47
Diluted Earnings per share
0.26
0.75
0.66
0.58
0.41
0.59
0.47
Operating Profit Margin (Excl OI)
17.48%
16.79%
16.4%
14.6%
13.48%
19.75%
15.0%
Gross Profit Margin
12.74%
22.45%
22.49%
20.52%
17.95%
21.43%
19.63%
PAT Margin
4.71%
14.63%
13.97%
12.35%
9.58%
13.69%
12.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 8.02% vs 8.83% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -61.88% vs 11.68% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 10.66% vs 8.92% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 46.87% vs 33.33% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Well Lead Medical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,620.13
0
1,620.13
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,620.13
0
1,620.13
Raw Material Cost
934.06
0
934.06
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
18.79
0
18.79
Selling and Distribution Expenses
275.62
0
275.62
Other Expenses
9.23
0.00
9.23
Total Expenditure (Excl Depreciation)
1,320.72
0
1,320.72
Operating Profit (PBDIT) excl Other Income
299.41
0.00
299.41
Other Income
11.13
0
11.13
Operating Profit (PBDIT)
370.40
0
370.40
Interest
18.79
0
18.79
Exceptional Items
-145.13
0
-145.13
Gross Profit (PBDT)
686.07
0
686.07
Depreciation
76.10
0
76.10
Profit Before Tax
130.38
0
130.38
Tax
43.16
0
43.16
Provisions and contingencies
0
0
0.00
Profit After Tax
76.33
0
76.33
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
76.33
0
76.33
Share in Profit of Associates
0
0
0.00
Minority Interest
10.80
0
10.80
Other related items
0.00
0.00
0.00
Consolidated Net Profit
87.13
0
87.13
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,761.69
0
1,761.69
Earnings per share (EPS)
0.26
0
0.26
Diluted Earnings per share
0.26
0
0.26
Operating Profit Margin (Excl OI)
17.48%
0%
0.00
17.48%
Gross Profit Margin
12.74%
0%
0.00
12.74%
PAT Margin
4.71%
0%
0.00
4.71%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 162.01 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 8.02% vs 8.83% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 8.71 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -61.88% vs 11.68% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 35.93 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 10.66% vs 8.92% in Dec 2024
Annual - Interest
Interest 1.88 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 46.87% vs 33.33% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.48%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






